Body Central CRASHES 47% and 4 Hot Stocks in the Crosshairs
Body Central Corp (NASDAQ:BODY) expects Q2 EPS to be around $0.19-$0.21, which is short of analysts’ consensus estimate of $0.27. The company notes continues soft comparable store sales and the necessity for an aggressive markdown of slow moving items as factors which sharply reduced guidance. The shares are down 24.9% premarket.
Don’t Miss: Rite Aid First Quarter Earnings Sneak Peek.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) has announced its interim data resulting from a Phase 2, doubl-blind, random, placebo-controlled study of saridegib in patients suffering from metastic or locally advanced, inoperable chondrosarcoma. Progression-free survival was the main endpoint of this Phase 2 study.
Extorre Gold Mines Ltd (NYSEAMEX:XG): According to Yamana gold, it has entered into a definitive agreement with Extorre Gold Mines (XG) in which Yamana should acquire all of Extorre’s issued and outstanding common shares.
Elster Group SE ADR (NYSE:ELT) has entered dicussions with Melrose PLC about a possible agreement in which Melrose would make a cash offer for Elster’s outstanding shares at $20.50 per ADS, totaling nearly $2.3B in aggregate on a fully diluted basis.
China Finance Online Co. (NASDAQ:JRJC) has announced the exclusive partnership between its flagship portal site Stockstar.com and Baidu.com in order to create a mobile web application which should provide financial information services. As a result of the partnership. Stockstar and Baidu have launched a mobile web application which integrates the reliable financial information services of Stockstar with advanced internet technologies.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.